JAMA Psychiatry. 2025 Dec 3. doi: 10.1001/jamapsychiatry.2025.3639. Online ahead of print. ABSTRACT IMPORTANCE: Individuals with schizophrenia spectrum disorders treated with second-generation antipsychotics (SGAs) are at …
JAMA Netw Open. 2025 Dec 1;8(12):e2546421. doi: 10.1001/jamanetworkopen.2025.46421. NO ABSTRACT PMID:41335443 | DOI:10.1001/jamanetworkopen.2025.46421
Rheumatology (Oxford). 2025 Dec 3:keaf645. doi: 10.1093/rheumatology/keaf645. Online ahead of print. ABSTRACT OBJECTIVES: To evaluate the clinical features and diagnostic work-up of patients with Chronic …
Bioinformatics. 2025 Dec 3:btaf650. doi: 10.1093/bioinformatics/btaf650. Online ahead of print. ABSTRACT MOTIVATION: Single-cell technologies enable high-resolution cellular studies but face challenges in identifying differential features …
Blood. 2025 Nov 10:blood.2024028042. doi: 10.1182/blood.2024028042. Online ahead of print. ABSTRACT We evaluated 108 pediatric patients with bone marrow failure and leukemia predisposition for presence …
Mol Neurobiol. 2025 Dec 3;63(1):240. doi: 10.1007/s12035-025-05482-4. ABSTRACT Pachymic Acid (PA), identified for its potential therapeutic efficacy in cerebral ischemic injury, has raised questions regarding …
Drugs. 2025 Dec 3. doi: 10.1007/s40265-025-02269-8. Online ahead of print. ABSTRACT Elamipretide (Forzinity™) is a mitochondrial cardiolipin binder being developed by Stealth BioTherapeutics for the …
Matern Child Health J. 2025 Dec 3. doi: 10.1007/s10995-025-04197-1. Online ahead of print. NO ABSTRACT PMID:41335360 | DOI:10.1007/s10995-025-04197-1
Clin Genet. 2025 Dec 3. doi: 10.1111/cge.70119. Online ahead of print. ABSTRACT This case highlights the complexity of diagnosing dual rare metabolic diseases and the …
Pediatr Allergy Immunol. 2025 Dec;36(12):e70247. doi: 10.1111/pai.70247. ABSTRACT BACKGROUND: Biologics have been shown to substantially reduce the risk of severe asthma exacerbations (SAEs) among children …
